Evidence map›Paper›PMID 28596392›Full record

ArticleGenome announcements2017

Fourteen Draft Genome Sequences for the First Reported Cases of Azithromycin-Resistant

Micheál Mac Aogáin, Nicholas Fennelly, Anne Walsh, Yvonne Lynagh, Michaël Bekaert, Brendan Lawlor, Paul Walsh, Brian Kelly, Thomas R Rogers, Brendan Crowley

Abstract read
In one paragraph

Article in Genome announcements, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Microbial genomics · 2021
    Article
  2. Review
  3. Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Micheál Mac AogáinDepartment of Clinical Microbiology, Trinity Translational Medicine Institute, School of Medicine, Trinity College Dublin, Dublin, Ireland m.macaogain@tcd.ie.ORCID http://orcid.org/0000-0002-1726-7700
Nicholas FennellyVirology Laboratory, St. James's Hospital, Dublin, Ireland.
Anne WalshVirology Laboratory, St. James's Hospital, Dublin, Ireland.
Yvonne LynaghVirology Laboratory, St. James's Hospital, Dublin, Ireland.
Michaël BekaertNSilico, Nova Center, Belfield Innovation Park, Dublin, Ireland.
Brendan LawlorNSilico, Nova Center, Belfield Innovation Park, Dublin, Ireland.
Paul WalshNSilico, Nova Center, Belfield Innovation Park, Dublin, Ireland.
Brian KellyNSilico, Nova Center, Belfield Innovation Park, Dublin, Ireland.
Thomas R RogersDepartment of Clinical Microbiology, Trinity Translational Medicine Institute, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Brendan CrowleyVirology Laboratory, St. James's Hospital, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we report the draft genome assemblies of 14 azithromycin-resistant

Identifiers

PMID28596392
PMCPMC5465611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.